MDGL

Madrigal Pharmaceuticals (MDGL)

About Madrigal Pharmaceuticals (MDGL)

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Details

Daily high

$517.54

Daily low

$500.80

Price at open

$513.23

52 Week High

$615.00

52 Week Low

$276.67

Market cap

11.7B

Dividend yield

0.00%

Volume

281,844

Avg. volume

280,410

P/E ratio

-39.51

Madrigal Pharmaceuticals News